LeConte Wealth Management
ALAB icon

LeConte Wealth Management’s Astera Labs ALAB Stock Holding History

LeConte Wealth Management’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$256K Buy
+720
New +$232K 0.14% 141

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $49B AUM 42.07% 1-Year Est. Return

LeConte Wealth Management's ALAB Position: Q3 2026 in Review

LeConte Wealth Management opened a new position in Astera Labs (ALAB) in Q3 2026: 720 shares worth $256K. The stake represents 0.14% of the portfolio and ranks #141 among its holdings.

673 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • LeConte Wealth Management held 720 shares of Astera Labs worth $256K as of Q3 2026.
  • Astera Labs was a new LeConte Wealth Management position in Q3 2026.
  • Astera Labs made up 0.14% of LeConte Wealth Management's portfolio in Q3 2026, its #141 holding.
  • 673 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on LeConte Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.